VISCHER advised LASCCO SA on all legal issues related to the license agreement. LASCCO SA, a biomedical-technology company, and Abionic SA, a nanotechnology company, both based...
LASCCO SA and Abionic SA’s License Agreement With Fapon
Ningbo Shanshan’s $310.5 Million GDRs Issuance and Listing on The SIX Swiss Exchange
Vischer, Advestra and Grandway advised Ningbo Shanshan on the deal. Niederer Kraft Frey has advised the underwriters led by Huatai Financial Holdings (Hong Kong) Limited and...
Haya Therapeutics’ CHF 18 Million Seed Round
VISCHER advised Haya Therapeutics SA on all legal issues related to the financing round. HAYA Therapeutics SA, a company developing precision medicines that target tissue and...
Haya Therapeutics’ CHF 18 Million Seed Round
VISCHER advised Haya Therapeutics SA on all legal issues related to the financing round. HAYA Therapeutics SA, a company developing precision medicines that target tissue and...
CITIC Capital Partners’ $50 Million Investment in MedAlliance SA
VISCHER advised CITIC on all Swiss law matters. Trustar Capital (formerly known as CITIC Capital Partners), a private equity affiliate of CITIC Capital Holdings Limited, has...